English

Malaysian Variation Guideline for Pharmaceutical Products (second edition, July 2022)

Written by Ng Pei Ling · 12 August 2022

This browser cannot display the document inline.

Open the PDF

This Malaysian Variation Guideline concerns the variation applications submitted by the PRH for pharmaceutical products for human use only. It is intended to provide supportive information on the requirements for submission of a variation application to implement a change to a pharmaceutical product. 

 

Download in PDF

Rate this page

Not yet rated